Atul Pande

CMO, EVP, SAB Member

Atul is an industry veteran, with more than 25 years of experience in psychiatry and neurosciences. Most recently, he was Senior Vice President and Senior Advisor, Pharmaceutical R&D at GlaxoSmithKline. He has been active in the development of many important CNS drugs while holding various senior roles in Pfizer R&D, Parke-Davis/Warner-Lambert, and Lilly Research Laboratories. His experience includes pre-IND development, proof of concept to registration development, launch and lifecycle management in the areas of anxiety, depression, epilepsy, neuropathic pain, schizophrenia, traumatic brain injury, and Alzheimer’s and Parkinson’s disease.

Atul is a psychiatrist and Fellow of several scientific societies. He began his career as a faculty member at the University of Michigan Medical School where his research focused on mood disorders. He has published over 50 peer-reviewed scientific papers and over 100 abstracts, book chapters, and book reviews.